Table 6.
Risk factors | ROP patients | Non-ROP subjects | t | P | |
---|---|---|---|---|---|
Neonatal factors | Gestational age (w) | 30.3±2.2 | 32.0±2.0 | t=6.97 | <0.001 |
Birth weight (g) | 1415±305 | 1660±350 | t=6.18 | <0.001 | |
Total days of oxygen supplement (d)* | 27.2±21.8 | 14.3±12.2 | t=–5.46 | <0.001 | |
Days of mechanical ventilation (d) | 3.6±8.8 | 1.4±3.5 | t=–3.75 | <0.001 | |
Days of non-mechanical ventilation (d)** | 23.6±18. 4 | 12.9±11.3 | t=–5.35 | <0.001 | |
Sex (M/F) | 50/42 | 212/155 | χ2=0.351 | 0.554 | |
Neonatal pneumonia | 87 | 346 | χ2=0.011 | 0.915 | |
ARDS, apnea, respiratory failure, asphyxia | 55 | 160 | χ2=7.739 | 0.005 | |
Pulmonary hemorrhage | 6 | 21 | χ2=0.085 | 0.771 | |
Encephalopathy of preterm infants | 78 | 255 | χ2=8.647 | 0.003 | |
Sepsis | 11 | 34 | χ2=0.603 | 0.437 | |
Congenital heart diseases | 47 | 163 | χ2=1.320 | 0.251 | |
Myocardial injury | 55 | 254 | χ2=2.972 | 0.085 | |
Coagulation dysfunction | 45 | 179 | χ2=0.001 | 0.981 | |
Hyperbilirubinemia, pathological jaundice | 49 | 203 | χ2=0.125 | 0.724 | |
Hypoproteinemia | 36 | 98 | χ2=5.496 | 0.019 | |
Hypoglycemia | 9 | 39 | χ2=0.056 | 0.813 | |
Hyperglycemia | 16 | 37 | χ2=3.848 | 0.050 | |
Anemia | 78 | 255 | χ2=8.647 | 0.003 | |
Acid-base imbalance | 47 | 167 | χ2=0.921 | 0.337 | |
Oxygen supplement | 90 | 331 | χ2=5.648 | 0.017 | |
Mechanical ventilation | 29 | 90 | χ2=1.876 | 0.171 | |
Blood transfusion | 77 | 206 | χ2=23.642 | <0.001 | |
Multiple deliveries | 28 | 123 | χ2=2.399 | 0.494 | |
Vasoactive substances | 57 | 152 | χ2=12.513 | <0.001 | |
Pulmonary surfactant | 22 | 49 | χ2=6.275 | 0.012 | |
Erythropoietin | 15 | 49 | χ2=0.535 | 0.465 | |
Maternal factors | Maternal age | 29.45±5.79 | 29.11±5.45 | t=–0.516 | 0.606 |
Eutocia/Cesarean section | 43/49 | 158/209 | χ2=0.406 | 0.524 | |
premature rupture of fetal membranes | 36 | 156 | χ2=0.001 | 0.977 | |
Amniotic fluid abnormalities | 5 | 27 | χ2=0.419 | 0.517 | |
Fetal distress | 10 | 45 | χ2=0.135 | 0.713 | |
Placenta praevia | 3 | 32 | χ2=3.112 | 0.078 | |
Placental abruption | 3 | 10 | χ2<0.001 | 1.000 | |
Gestational hypertension | 7 | 34 | χ2=0.248 | 0.619 | |
Gestational cholestasis | 5 | 87 | χ2=0.002 | 0.961 | |
Gestational diabetes | 2 | 20 | χ2=1.086 | 0.297 | |
Anemia in pregnancy | 5 | 24 | χ2=0.152 | 0.697 | |
Cold | 25 | 110 | χ2=0.278 | 0.598 | |
Dexamethasone | 20 | 101 | χ2=1.267 | 0.26 | |
Penicillin | 1 | 14 | χ2=0.976 | 0.323 | |
Tocolytic agents | 5 | 11 | χ2=0.676 | 0.411 |
Total days of oxygen supplementation = days of mechanical ventilation + days of non-mechanical ventilation;
Days of non-mechanical ventilation = total days of oxygen supplementation via nasal tube, mask or chamber.
ROP – retinopathy of prematurity; ARDS – Acute Respiratory Distress Syndrome; HIE – hypoxic-ischemic encephalopathy.